The effect of obesity on echocardiographic and metabolic parameters in childhood

Sibel Tulgar Kinik1, Birgül Varan, Selman Vefa Yildirim

  • 1Department of Pediatrics, Başkent University Faculty of Medicine, Ankara, Turkey. stkinik@hotmail.com

Insights

Obese children show left ventricular hypertrophy (LVH) linked to higher body mass index (BMI), insulin, and lipid levels. Tissue Doppler imaging (TDI) detected early diastolic dysfunction in the right ventricle and interventricular septum.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Physiology
  • Metabolic Disorders

Background:

  • Obesity in children is associated with increased risk of left ventricular (LV) hypertrophy and cardiac dysfunction.
  • Conventional echocardiography and tissue Doppler imaging (TDI) are key tools for assessing cardiac function.
  • Metabolic markers like glucose, lipids, and insulin play a role in cardiac health.

Purpose of the Study:

  • To evaluate ventricular function in obese children using echocardiography and TDI.
  • To correlate cardiac function parameters with metabolic markers (glucose, lipids, insulin).
  • To identify subclinical cardiac changes in pediatric obesity.

Main Methods:

  • Conventional echocardiography and TDI were performed on 30 obese children and an age-matched control group.
  • Fasting serum glucose, lipid profiles, and insulin levels were measured in obese children.
  • Left ventricular mass (LVM), relative wall thickness (RWT), and LV end-diastolic diameter were assessed.

Main Results:

  • Obese children had significantly greater LVM/ht2.7, RWT, and LV end-diastolic diameter compared to controls.
  • Diastolic function (E/A ratio) of the right ventricle and interventricular septum (IVS) was reduced in obese children.
  • LVM/ht2.7 and RWT correlated with BMI; IVS and LV posterior wall thickness correlated with insulin, VLDL, and triglycerides.

Conclusions:

  • Obese children exhibit left ventricular hypertrophy (LVH) associated with elevated BMI, insulin, and lipid levels.
  • TDI revealed subclinical diastolic dysfunction in the right ventricle and IVS in obese children.
  • These findings highlight the cardiac impact of pediatric obesity and associated metabolic derangements.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...